| Literature DB >> 22294856 |
Ujjal Sarkar1, Rainer Glaser, Zack D Parsons, Charles L Barnes, Kent S Gates.
Abstract
1,2,4-Benzotriazine 1,4-di-N-oxides are potent antitumor drug candidates that undergo in vivo bioreduction leading to selective DNA damage in the low oxygen (hypoxic) cells found in tumors. Tirapazamine (TPZ) is the lead compound in this family. Here we report on the synthesis, crystal structure, and conformational analysis of a new analog, 3-cyclopropyl-1,2,4-benzotriazine 1,4-di-N-oxide (3). Compound 3 (C(10)H(10)N(3)O(2)) crystallized in the monoclinic space group C2/c. Unit cell parameters for 3: a = 16.6306 (12), b = 7.799 (5), c = 16.0113 (11) Å, α = 90, β = 119.0440 (10), γ = 90, and z = 8.Entities:
Year: 2010 PMID: 22294856 PMCID: PMC3268128 DOI: 10.1007/s10870-010-9707-9
Source DB: PubMed Journal: J Chem Crystallogr ISSN: 1074-1542 Impact factor: 0.603